The Latest Breaking News from Brain

New drug is 'beginning of the end' of Alzheimer's - who will it help and when will it be available?

Lecanemab has been shown in trials to slow the progress of early-stage Alzheimer's by 27%

Wales Online · Nov 30, 2022

Woman struck by high-speed rollercoaster wakes up after spending two months in a coma

Shylah Rodden, 26, was put in a medically-induced coma after sustaining brain damage and serious injuries all over her body when she was hit by a 43mph rollercoaster at the Royal Melbourne Show on Septmeber 25

Daily Mirror · Nov 30, 2022

What is the difference between Alzheimer’s and dementia?

New drug proven to slow onset of degenerative brain disease as scientists hail ‘breakthrough’

The Independent UK · Nov 30, 2022

‘Momentous breakthrough’: New Alzheimer’s drug lives up to bold claims, with caveats

Data supports claims that a new drug reduced cognitive and functional decline in Alzheimer's patients by 27 per cent in a clinical trial.

The New Daily · Nov 30, 2022

Brain cancer: Seven possible symptoms to be aware of

From seizures to sudden weakness or speech disturbances, these are some of the red flags that could indicate the onset of the condition

The Independent UK · Nov 30, 2022

NHS ‘nowhere near ready’ to deliver new Alzheimer’s drug, doctors say

Patients unlikely to receive lecanemab before 2026 and health service does not yet have necessary infrastructure

The Guardian - UK · Nov 30, 2022

Nightmares have plagued humans for millennia — do we finally know how to tame them?

Neuroscientists and psychologists are researching new treatments that might help us finally understand why nightmares take over our minds and how to quell them.

Inverse · Nov 30, 2022

New Alzheimer's drug faces uncertain regulatory path

The FDA will soon decide whether to approve Eisai's experimental drug lecanemab.

Axios · Nov 30, 2022

Study: Alzheimer's drug shows modest success slowing declines in memory, thinking

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

WEKU · Nov 30, 2022

It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough

Recent lecanemab trials are reason for hope, although health services may struggle to deliver treatments, says dementia researcher Jonathan Schott

The Guardian - UK · Nov 30, 2022